chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Date of Consultation:  3/18/2022  Time of Consultation:  10:38 AM    Assessment & Plan:   Respiratory Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Assessment & Plan Symptoms of altered mental status cough sore throat fatigue requiring supplemental O2.   Vaccination status: partially last dose 5/5/2021 Symptom onset: Approximately 3/14 Test date: 3/17 O2 Management NC 3L SpO2: 95 %   Periods of desaturation, multifactorial, underlying sleep apnea plus minus superimposed Covid. Out of caution and high risk for progression, have offered dexamethasone along with remdesivir.  Patient appreciates and understands. This was addressed with internal medicine. Additionally it was recommended that he should reconnect with a sleep clinic to address sleep apnea.       Reason for Consultation: COVID 19   History of Present Illness: Patient is a 61y.o. year old male    This patient is very pleasant 61-year-old male who provides his own history.  He is not completely aware of the the circumstances precipitating admission however his fiancée indicates he was not appropriate mentally.  He also had elevated blood sugars.  In discussion today he indicates he had a sore throat and a cough associated with fatigue over the course of the 48 to 72 hours prior to admission.  He is not had previous infections with Covid virus.  He was vaccinated x2 injections last being in May.  He attempted to get his third dose of vaccine but was not able to coordinate.  Since admission he has been on nasal cannula.  This morning nursing found him to be sleeping but the setting into the upper 80s.  He was aroused placed on higher amounts of nasal cannula i.e. 5 to 6 L/min and recovered quickly.  During my evaluation he was placed on nasal cannula.  After about 15 to 20 minutes he was satting at about 88 to 89% without tachycardia.  Placement of nasal cannula back to 2 to 3 L yielded an SPO2 of approximately 93 to 95%.  He does admit to wearing a nocturnal mask at about 2008 following a sleep study test by a physician previously practicing.  He only used the mask for about 6 months.  He never did return for subsequent evaluations and knows that the clinic is currently closed.     Addressed primary therapy for mild to moderate Covid.  Patient concurs with the combination of steroids and remdesivir.     Vaccination status: partially last dose 5/5/2021 Symptom onset: Approximately 3/14 Test date: 3/17 O2 Management NC 3L SpO2: 95 %   COVID 19 INFLAMMATORY MARKERS:
Fever/Undocumented fever; Chills; Numbness left body; Metallic taste; Headache; Body aches; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiration date were not reported), via an unspecified route of administration on 05Jan2021 16:45 at single dose on the left arm for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was taking an unspecified concomitant medication. The patient previously took first dose of BNT162B on 26Jan2021 at 16:15 for COVID-19 immunization. On 05Jan2021 at 18:00, the patient experienced every reaction that was possible to the vaccine including fever (also reported as undocumented fever), chills, numbness left body, metallic taste, headache, body aches, diarrhea, and fatigue. The events were reported as non-serious and no treatment was given to the patient. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 with unknown results at the time of the report. The patient recovered from all of the events on an unspecified date.    Information on the lot/batch number has been requested.
This spontaneous report was received from a registered nurse refers to a female patient (age unknown). On an unknown date, the patient was vaccinated with PNEUMOVAX23 (dose, route, lot number not provided). Concomitant medication was not reported. On an unknown date, the patient was administered PNEUMOVAX23 and developed a pink swollen ring like area where she was vaccinated. At the time of the report, the outcome of pink swollen ring like area where she was vaccinated was unknown. Pink swollen ring like area where she was vaccinated was unknown related to PNEUMOVAX23. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), on 08Feb2021 as dose 1, single (Lot number: EN6201), on 09Mar2021 as dose 2, single (Lot number: EN6199) and on 09Nov2021 as dose 3 (booster), single (Lot number: FG3527) at the age of 59 years for COVID-19 immunization. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "Chronic coughing" (unspecified if ongoing), notes: History of chronic coughing but all three chest X-rays performed in 2020 were negative. Concomitant medication(s) included: AMLODIPINE BENAZEPRIL, start date: 01Jan2015. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: Cough: (2020) Negative; (2020) Negative; (2020) Negative; SARS-CoV-2 test: (11May2021) Positive, notes: clearly positive again after 1 week from last dose. Therapeutic measures were taken as a result of COVID-19; Anti-viral (Paxlovid) treatment start date=29Apr2022, treatment stop date=04May2022.
COVID positive Narrative: Patient is a resident and received his first COVID vaccine on 12/28/20. On 1/4/21, he had a COVID routine screen done that returned positive on 1/6/21. Per notes, he was asymptomatic at the time; however for isolation purposes, he was transferred to acute care medicine services. On 1/7/21, he was noted to have a slight increase in BUN/creatinine ratio thought to be due to volume depletion and has been ordered IV fluids. He still remains free of any respiratory symptoms at this time.
Shingles. Went to clinic on 4/11 was diagnosed with shingles was put on medication. Medication is over, I still have shingles, the rash, nerve pain, itching.
On 7/2/2021, the patient presented to clinic  in the  system with complaints of jaundice. Symptoms had been present for several days prior to this. She was found to have acute liver failure  (AST 933, ALT 816, Bilirubin 12.8, Albumin 3.0)  and was hospitalized at hospital. She had a liver biopsy on 7/6 which was consistent with severe acute hepatitis with hepatocyte loss (see more below).  She was treated with steroids and discharged home. She was readmitted to Hospital on  7/21 after a syncopal event and with continued worsening liver failure. She was transferred to the medical center on 7/23 for evaluation by transplant hepatology.
within 24 hours her smoker's cough of sixty years lessened. Her sinuses also cleared up completely.  She has a cat and she's not allergic, but she does have a sensitivity and her sinuses get activated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71-year-old female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 31Oct2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 71 years, in right arm for immunisation; for immunisation. The patient's relevant medical history included: "smallpox" (unspecified if ongoing); "yellow fever" (unspecified if ongoing); "smoker's cough" (unspecified if ongoing), notes: had it for 60 years. Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, in Oct2023 as dose number unknown, single, in Oct2023 as dose number unknown, single; PNEUMOCOCCAL VACCINE taken for immunisation, in Oct2023 as dose number unknown, single; SHINGRIX taken for immunisation, in Oct2023 as dose 2, single. Vaccination history included: Bnt162b2 (History of all previous immunization with the Pfizer vaccine considered as suspect: 1st dose), for COVID-19 immunization; Shingrix (1st shot was shingles in Sep2023), administration date: Sep2023. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious) with onset 2023, outcome "unknown", described as "within 24 hours her smoker's cough of sixty years lessened. Her sinuses also cleared up completely.  She has a cat and she's not allergic, but she does have a sensitivity and her sinuses get activated". Additional information: Caller, aged 71, received the Abrysvo vaccine on 31Oct2023 at withheld, and within 24 hours her smoker's cough of sixty years lessened. Her sinuses also cleared up completely. She has a cat and she's not allergic, but she does have a sensitivity and her sinuses get activated. That went away after taking the Abrysvo. History of all previous immunization with the Pfizer vaccine considered as suspect was 1st dose. Additional Vaccines Administered on Same Date of the Pfizer Suspect was annual flu shot. Prior Vaccinations (within 4 weeks) included going through series of shingle shot and Covid update and 2 flu and today got pneumonia shot.1st shot was shingles in Sep2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
C/o redness, pain and swelling at injection site. Extreme sweating, swelling in arm, mouth sores, swollen glands, body aches, loss of appetite, fatigue & fever. Symptoms started 3/26/2021 the next day around noon. Took tramadol and tylenol and anti-nausea medicine. Feeling better today, still has site injection pain, everything else has resolved. COVID + March 2020. -
01/13/23 presents to ED for "chest pain". PMHx of "hypertension depression osteoarthritis"
Pt. received immunizations as below. Within min. he experienced tightness in his throat, followed by swelling in his lips, followed by swelling in his eyes. No shortness of breath or rash. Did get redness around eyes.
Client reports developed rash across face from ear to chin, on chest and over right shoulder. Clt describes rash as slightly red and raised, more congested below right ear. Fatigue and mild HA also reported. Client feels well enough to work, symptoms mild to moderate, will continue to observe and will call if worsens or does not improve. 6/29/05 client reports increase in symptoms this AM. Reports rash on head, neck, chest, arms, under arms and bottom of feet. Eyes, nose and ears itch. Glands in neck swollen. Sensitive to light and touch. Denies medical follow up with other providers. Requested to see Dr. TC to Dr. Dr sugg clt follow up in ER. Clt reached on cell phone. Inc to go to ER.
postherpetic neuralgia (PHN).; painful and debilitating outbreak of shingles; Information has been received from a lawyer regarding a case in litigation and referred to a male patient of unknown age. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not provided. On 09-NOV-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) as routine health maintenance and the prevention of shingles (strength, dose, route of administration, site of administration, lot number and expiration date were not provided). On an unknown day in February 2016 (also reported as "shortly after receiving the Company's zoster vaccine live (ZOSTAVAX) vaccine"), the patient suffered a painful and debilitating outbreak of shingles (herpes zoster) which became reoccurring and resulted in the diagnosis of postherpetic neuralgia (on an unspecified date). These conditions also resulted in hospitalization and extensive medical care. As a result of the patient's injuries, his wife, suffered loss of services and society and asserts a loss of consortium claim. As a direct and proximate result of the defective zoster vaccine live (ZOSTAVAX) vaccine, the patient suffered severe injuries and life-long disabilities not present prior to using zoster vaccine live (ZOSTAVAX). Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), patient sustained severe and disfiguring personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient and his wife have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. At the time of the report, the patient had not recovered from postherpetic neuralgia and herpes zoster. The causal relationship between zoster vaccine live (ZOSTAVAX) and pneumonia was reported as related.  Postherpetic neuralgia and herpes zoster were reported to be disabling events.
gave a booster dose to a patient instead of a full 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (gave a booster dose to a patient instead of a full 1st dose) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.  On 02-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (gave a booster dose to a patient instead of a full 1st dose). On 02-Dec-2021, ACCIDENTAL UNDERDOSE (gave a booster dose to a patient instead of a full 1st dose) had resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment medication use was not provided by the reporter.
Drooping of left side of face and weakness of leg. Patient doesn?t have a regular doctor. He consulted an online physician and was told it may be Bell?s Palsy. He was prescribed medrol dospak and valcyclovir. Leg seems to be better. But the patient still has drooping face on left side. He plans on seeing another doctor but started to wonder about the cause after reading more about the vaccine. Outcome is still unknown.
Dryness in his throat/ extremely, extremely sore and dry throat; Headaches; Feeling terrible; Fever; Chills; Chest pain; Oppression in his chest that does not allow him to breathe normally/ pressure in his chest not letting him breathe normally; Sore throat/ extremely, extremely sore and dry throat; Chest pain is like a pressure; This is a spontaneous report from a contactable consumer (patient himself) via Medical Information Team. A 43-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 27May2021 09:00 as 2nd dose, single dose (at the age of 43-years-old) for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as 1st dose, single dose for COVID-19 immunization. Patient mentions that yesterday (27May2021) he got the second dose of the Pfizer covid vaccine at 9 am and since then he had fever, chills, sore throat, chest pain like a pressure in his chest, oppression in his chest that does not allow him to breathe normally. On 28Feb2021, experienced dryness in his throat (extremely sore and dry throat), headache, feeling terrible. He wants to report the situation. Patient what should he do, does he need to go to a hospital.  Communication included Advising patient to seek medical attention or the care of a doctor. The outcome of the events was unknown.   No further information is provided or obtained. Information on lot/Batch number has been requested.
PATIENT FELT COLD (CHILLS) ,. PATIENT REFUSED EMERGENCY SERVICES AND/ OR TO CONTACT A DOCTOR.
In the morning of 2/11/21 received very bad headache, then once at work, shakes, trembling all over my body, sever pain behind right eye, upset stomach, cold/hot spells, heavy weight on my chest (breathing light and fast), dizzyness.  2/12/21 - upset stomach, headache, fatigue
A spontaneous report was received from a consumer concerning a old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced  little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold. The patient's medical history includes arthritis. No relevant concomitant medications were reported. On 10 Feb 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: 016M20A) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route for prophylaxis of COVID-19 infection. On 11 Feb 2021, the patient experienced little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold. Treatment details included ginger tea. Action taken with mRNA-1273 in response to the events was not reported. On an unknown date the outcome of little fever/pyrexia, bones hurting/arthralgia, felt cold/feeling cold was unknown.
Left arm became red, swollen and hot to touch from top of shoulder to elbow, and axillary region.   It was itchy.  Arm was tender to the touch. Onset 7/23/21 to 7/26/21.  Was treated with 40 mg of Prednisone once a day for 3 days
Received call from mother who stated that on 01/28, eight days post vax, child broke out in rash, had slight fever, not exceeding 100 degrees on 01/29 and 01/30. Reports severe itching. Also complained of some dizziness and occasional headache, but also displaying sinus congestion. Mother reported treating itching with Benadryl, 23 mg, every 4 hours calamine lotion and soda baths. Took child to the physician - waves second MMR.  02/10, mother reports, 'It took a week to get over rash.'
upon arising on 1/21 c/o redness, soreness and swelling measuring 1.5 in. x 2 in. Denies any symptoms following vaccination until 1/21.
really ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (really ill) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (really ill). At the time of the report, ILLNESS (really ill) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Severe fever and congestion as bad as when I had covid that lasted a week or so. Heart pressure began after a few days, radiating out from my sternum. The pressure came and went a few times, and though I resisted the first few opisodes, it ended up finally necessitating an ER visit. In the beginning I started taking sudafed (the kind they check ID for, that works) and tylenol and had electronic followup with my doctor vioa email. The fever and congestion broke about an hour after I was prayed for in our temple services Friday night (I'm not saying it is connected, but I am also not saying it is not. ;) ) The heart pressure continued to come and go in pules and episodic periods lasting an hour or two, except the last time on 9/24. I realize 9/24 is quite a while after the shot, however the problems started right after the shot and my heart has been checked regularly and never had any trouble before.  It really has not gone away, by the way. I still have bits of radiating chest pressure here and there.
Patient reports a rash, fever and headache that started on Friday and continued until Sunday.  The fever and headache were relieved with acetaminophen.  The patient reports no fever and headache on 9/1/2009.  There is a faint outline of a rash that remains at the injection site.
Right anterolateral mid arm swollen and itching and hot. DTAP was given 2 days ago.
Diluent was inadvertently not added to vial. Vaccine dose was 0.2 ml of undiluted vaccine   Reporting incorrect administered dose as adverse event No clinical effects at this time
Did not have antibodies; This spontaneous case was reported by an other and describes the occurrence of ANTIBODY TEST NEGATIVE (Did not have antibodies) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANTIBODY TEST NEGATIVE (Did not have antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (Did not have antibodies) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported. No treatment information provided.
Information has been received from a consumer concerning his daughter, a 5 year old female who in October 2007 was vaccinated with VARIVAX (Merck). Subsequently, on 07-Oct-2008 it was reported the daughter was diagnosed with zoster. She is being treated with "Zorivax". Whether she sought medical attention and the patient outcome were unknown. Additional information has been requested.
4 days after immunization pt presented in office for follow up after ER visit. 6x6 cm area of redness/edema and tenderness to RT. Dx: cellulitis
I had severe heart palpitations both nights after receiving each dose of the vaccine. A little over 24 hours after my first shot, the whole left side of my neck and jaw had swollen out where my face looked distorted. Went to Emergency dept that night and Dr just simply stated he didn?t think it was from the vaccine. I had never had anything like this ever happen to me before.  The swelling/reaction went away by the next day.  In Early to mid April 2021 I was put on 25 mg metoprolol to help the heart palpitations and blood pressure. April 27th I had received the second dose of the vaccine and that evening the heart palpitations had gotten worse.